Literature DB >> 11104163

Contemporary diagnostic approach in Alport's syndrome.

J P Grünfeld1.   

Abstract

Diagnosis of Alport's syndrome rests on clinical, pathological and genetic criteria. The clinical criteria include positive family history, persistent microhematuria and extrarenal abnormalities involving eyes and ears. Besides kidney biopsy, skin biopsy has emerged recently as an interesting diagnostic tool: the absence of staining for the alpha5 chain of type IV collagen in the epidermal basement membrane is highly specific of x-linked Alport's syndrome but its sensitivity is approximately 75%. Genetic diagnosis is based on direct identification of the mutation involved (positive in 50% of the families, after long and tedious search) or on linkage analysis. An integrated approach to diagnosis of Alport's syndrome (which encompasses various diseases characterized by different molecular defects) has been greatly facilitated in the last 10 years.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11104163     DOI: 10.1081/jdi-100101961

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  6 in total

Review 1.  Cutting edge issues in Goodpasture's disease.

Authors:  Andrew L Chan; Samuel Louie; Kevin O Leslie; Maya M Juarez; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

2.  Osteopontin deficiency ameliorates Alport pathology by preventing tubular metabolic deficits.

Authors:  Wen Ding; Keyvan Yousefi; Stefania Goncalves; Bradley J Goldstein; Alfonso L Sabater; Amy Kloosterboer; Portia Ritter; Guerline Lambert; Armando J Mendez; Lina A Shehadeh
Journal:  JCI Insight       Date:  2018-03-22

Review 3.  Familial hematurias: what we know and what we don't.

Authors:  Clifford E Kashtan
Journal:  Pediatr Nephrol       Date:  2005-04-27       Impact factor: 3.714

4.  The importance of non-invasive genetic analysis in the initial diagnostics of Alport syndrome in young patients.

Authors:  Maja Slajpah; Anamarija Meglic; Polonca Furlan; Damjan Glavac
Journal:  Pediatr Nephrol       Date:  2005-06-08       Impact factor: 3.714

5.  The Hypomorphic Variant p.(Gly624Asp) in COL4A5 as a Possible Cause for an Unexpected Severe Phenotype in a Family With X-Linked Alport Syndrome.

Authors:  Eva Pauline Macheroux; Matthias C Braunisch; Stephanie Pucci Pegler; Robin Satanovskij; Korbinian M Riedhammer; Roman Günthner; Oliver Gross; Mato Nagel; Lutz Renders; Julia Hoefele
Journal:  Front Pediatr       Date:  2019-11-26       Impact factor: 3.418

6.  Alport's Syndrome in Pregnancy.

Authors:  Suchita Mehta; Chadi Saifan; Marie Abdellah; Rita Choueiry; Rabih Nasr; Suzanne El-Sayegh
Journal:  Case Rep Med       Date:  2013-06-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.